Use of electrical stimulation therapy to reduce pain associated with hard-to-heal wounds and reduce reliance on pharmacological analgesics: a case series.
{"title":"Use of electrical stimulation therapy to reduce pain associated with hard-to-heal wounds and reduce reliance on pharmacological analgesics: a case series.","authors":"Maria Moon, Liz Hawes, Daphne Hazell","doi":"10.12968/jowc.2024.0235","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess the effect of microcurrent electrical stimulation therapy (EST) on pain from hard-to-heal wounds and quantity/type of analgesic needed in its management.</p><p><strong>Method: </strong>Patients with painful, stalled leg ulcers were treated with microcurrent EST. Pain scores (0-10 on a numerical rating scale (NRS)) and analgesic consumption were recorded daily for a seven-day run-in period and during treatment with EST for 24 days. Patients were followed up for six months.</p><p><strong>Results: </strong>There were 20 patients in the experimental cohort. The median wound duration was nine months (range: 1.5-60 months); wounds included venous (14/20), arterial (5/20) and mixed aetiology (1/20) ulcers. Mean wound pain reduced significantly, from a value of 5.7 at baseline to 3.7 after 24 days of treatment (n=20; p<0.0001). Median time to achieve no/mild pain (NRS 0-4) was five weeks after the start of treatment. The median number of analgesics being taken for wound pain reduced between baseline and end of treatment from 2 to 1 (range: 0-4 at both timepoints). Mean daily dose reductions were observed for gabapentin, ibuprofen and paracetamol. Among patients taking analgesics for wound pain at baseline, 3/19 were able to discontinue all analgesia. After initiation of EST, the mean wound size reduction was 41% over four weeks, (10.2% reduction per week). The median time to healing was 18 weeks.</p><p><strong>Conclusion: </strong>In this clinical evaluation, patients treated with microcurrent EST reported reduction in pain and reduced analgesic consumption.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 11","pages":"932-940"},"PeriodicalIF":1.7000,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of wound care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12968/jowc.2024.0235","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To assess the effect of microcurrent electrical stimulation therapy (EST) on pain from hard-to-heal wounds and quantity/type of analgesic needed in its management.
Method: Patients with painful, stalled leg ulcers were treated with microcurrent EST. Pain scores (0-10 on a numerical rating scale (NRS)) and analgesic consumption were recorded daily for a seven-day run-in period and during treatment with EST for 24 days. Patients were followed up for six months.
Results: There were 20 patients in the experimental cohort. The median wound duration was nine months (range: 1.5-60 months); wounds included venous (14/20), arterial (5/20) and mixed aetiology (1/20) ulcers. Mean wound pain reduced significantly, from a value of 5.7 at baseline to 3.7 after 24 days of treatment (n=20; p<0.0001). Median time to achieve no/mild pain (NRS 0-4) was five weeks after the start of treatment. The median number of analgesics being taken for wound pain reduced between baseline and end of treatment from 2 to 1 (range: 0-4 at both timepoints). Mean daily dose reductions were observed for gabapentin, ibuprofen and paracetamol. Among patients taking analgesics for wound pain at baseline, 3/19 were able to discontinue all analgesia. After initiation of EST, the mean wound size reduction was 41% over four weeks, (10.2% reduction per week). The median time to healing was 18 weeks.
Conclusion: In this clinical evaluation, patients treated with microcurrent EST reported reduction in pain and reduced analgesic consumption.
期刊介绍:
Journal of Wound Care (JWC) is the definitive wound-care journal and the leading source of up-to-date research and clinical information on everything related to tissue viability. The journal was first launched in 1992 and aimed at catering to the needs of the multidisciplinary team. Published monthly, the journal’s international audience includes nurses, doctors and researchers specialising in wound management and tissue viability, as well as generalists wishing to enhance their practice.
In addition to cutting edge and state-of-the-art research and practice articles, JWC also covers topics related to wound-care management, education and novel therapies, as well as JWC cases supplements, a supplement dedicated solely to case reports and case series in wound care. All articles are rigorously peer-reviewed by a panel of international experts, comprised of clinicians, nurses and researchers.
Specifically, JWC publishes:
High quality evidence on all aspects of wound care, including leg ulcers, pressure ulcers, the diabetic foot, burns, surgical wounds, wound infection and more
The latest developments and innovations in wound care through both preclinical and preliminary clinical trials of potential new treatments worldwide
In-depth prospective studies of new treatment applications, as well as high-level research evidence on existing treatments
Clinical case studies providing information on how to deal with complex wounds
Comprehensive literature reviews on current concepts and practice, including cost-effectiveness
Updates on the activities of wound care societies around the world.